Skip to content

Clinical trials

Recruiting Pulmonary Disease, Chronic Obstructive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Status: Recruiting Country / region: China Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20221
20236
202411
202525
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting58

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China-Japan Friendship Hospital7
AstraZeneca5
Beijing Chao Yang Hospital3
Sanofi3
First Affiliated Hospital of Ningbo University2
GlaxoSmithKline2
Guangdong Hengrui Pharmaceutical Co., Ltd2
Haisco Pharmaceutical Group Co., Ltd.2
Nanfang Hospital, Southern Medical University2
Shanghai Chest Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive58
Asthma7
Bronchiectasis5
Emphysema5
Lung Diseases4
Bronchitis, Chronic3
Disease3
Heart Failure2
Lung Neoplasms2
Sleep Apnea, Obstructive2

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.